SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
31-May-24 4:56 PM View: | Larimar Therapeutics, Inc. (LRMR) | 16-Feb-24 | Market Purchase | 57,208 | $8.74 | $499,998.00 | 9% 667.02K to 724.23K | 5% |
20-Sep-22 6:54 AM View: | Larimar Therapeutics, Inc. (LRMR) | 16-Sep-22 | Private Purchase | 317,460 | $3.15 | $999,999.00 | 91% 349.56K to 667.02K | |
04-May-21 4:31 PM View: | Annaly Capital Management, ... (NLY) | 03-May-21 | Market Sale | 80,000 | $9.18 | $734,432.00 | (15%) 540.0K to 460.0K | 10% |
30-Jun-20 5:02 PM View: | Larimar Therapeutics, Inc. (LRMR) | 26-Jun-20 | Acquisition (other) | 133,420 | -- | -- | 100% 133.42K to 266.84K | |
30-Jun-20 5:02 PM View: | Larimar Therapeutics, Inc. (LRMR) | 26-Jun-20 | Acquisition (other) | 159,433 | -- | -- | 60% 266.84K to 426.27K | |
15-May-20 4:58 PM View: | Annaly Capital Management, ... (NLY) | 15-May-20 | Market Purchase | 200,000 | $5.96 | $1,192,920.00 | 59% 340.0K to 540.0K | 24% |
20-May-19 7:08 AM View: | Annaly Capital Management, ... (NLY) | 17-May-19 | Market Purchase | 30,000 | $9.47 | $284,094.00 | 12% 250.0K to 280.0K | (31%) |
20-May-19 7:08 AM View: | Annaly Capital Management, ... (NLY) | 17-May-19 | Market Purchase | 60,000 | $9.47 | $568,200.00 | 21% 280.0K to 340.0K | (31%) |